Literature DB >> 10708576

Cyclosporin A induces an atypical heat shock response.

L Paslaru1, M Rallu, M Manuel, S Davidson, M Morange.   

Abstract

Cyclosporin A is a widely used immunosuppressive drug having toxic side effects, in particular on kidneys and liver, as a result of its action on different molecular targets. Here we demonstrate that low doses of CsA are able to induce the expression of the heat shock protein HSP27 and its hyperphosphorylation. It also activates the two heat shock transcription factors, HSF1 and HSF2. Since these factors have been shown to be activated by proteasome inhibition, we tested the hypothesis that the inhibitory action of CsA on the proteasome might be responsible for the activation of HSFs and the subsequent expression of HSP27. The increase in multiubiquitinated proteins as well as the stabilization of p53 following CsA addition argues in favor of this hypothesis. The kidney BSC-1 cells are highly responsive to the addition of CsA: the possible link between HSP27 induction and hyperphosphorylation and nephrotoxicity is discussed. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708576     DOI: 10.1006/bbrc.2000.2295

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Stress-specific activation and repression of heat shock factors 1 and 2.

Authors:  A Mathew; S K Mathur; C Jolly; S G Fox; S Kim; R I Morimoto
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via ROS generation, iNOS and Hsp70.

Authors:  Huei-Wen Chen; Chiang-Ting Chien; Sung-Liang Yu; Yuan-Teh Lee; Wen-Jone Chen
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  The effect of Cyclosporine A on cardiomyocytes differentiation.

Authors:  Liliana Paslaru; Sean Davidson; Irinel Popescu; Michel Morange
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.